These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients. Luer MS Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896 [No Abstract] [Full Text] [Related]
27. Felbamate: consensus of current clinical experience. Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038 [TBL] [Abstract][Full Text] [Related]
29. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview]. Steinhoff BJ Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894 [TBL] [Abstract][Full Text] [Related]
30. FDA recommends taking patients off Felbatol. RDH; 1994 Sep; 14(9):36. PubMed ID: 8619071 [No Abstract] [Full Text] [Related]
31. Potential pharmacokinetic interaction between felbamate and phenobarbital. Gidal BE; Zupanc ML Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465 [TBL] [Abstract][Full Text] [Related]
32. Felbamate in an adult population with severe refractory epilepsy. Kearney H; Delanty N Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801 [TBL] [Abstract][Full Text] [Related]